Financhill
Sell
33

ORMP Quote, Financials, Valuation and Earnings

Last price:
$2.38
Seasonality move :
6.43%
Day range:
$2.37 - $2.49
52-week range:
$2.00 - $3.67
Dividend yield:
0%
P/E ratio:
21.64x
P/S ratio:
36.45x
P/B ratio:
0.61x
Volume:
100.5K
Avg. volume:
192.5K
1-year change:
8.68%
Market cap:
$95.9M
Revenue:
$1.3M
EPS (TTM):
$0.11

Earnings Data

Next earnings date for ORMP
May 09
2025
Most recent earnings per share
-$0.48
Missed by $0.46
(Nov 7/2024)
Consensus Estimate
-$0.02
(Nov 7/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

ORMP Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
12/31/2024 Q4 -- -- -- -$0.07 --
11/07/2024 Q3 -- -- -$0.48 -$0.02 -$0.46
08/14/2024 Q2 $250K -- $0.22 -$0.02 $0.24
05/09/2024 Q1 -- -- $0.04 -- --
12/31/2023 Q4 -- -- $0.33 -$0.01 $0.34
11/09/2023 Q3 -- -- -$0.08 -$0.09 $0.01
08/10/2023 Q2 -- -- -$0.03 -$0.09 $0.06
05/11/2023 Q1 -- -- -$0.08 -$0.25 $0.17
12/31/2022 Q4 -- -- -$0.22 -$0.25 $0.03
11/10/2022 Q3 -- -- -$0.18 -$0.26 $0.08
08/10/2022 Q2 -- -- -$0.27 -- --
08/10/2022 Q2 -- -- -- -$0.25 --
05/12/2022 Q1 -- -- -$0.27 -- --
05/12/2022 Q1 -- -- -- -$0.23 --
01/11/2022 Q4 -- -- -$0.22 -- --
08/31/2021 Q3 -- -- -$0.21 -- --
07/14/2021 Q2 -- -- -$0.17 -- --
04/13/2021 Q1 -- -- -$0.17 -- --
01/14/2021 Q4 -- -- -$0.23 -- --
08/31/2020 Q3 -- -- -$0.12 -- --
07/07/2020 Q2 -- -- -$0.10 -- --
04/06/2020 Q1 -- -- -$0.21 -- --
01/09/2020 Q4 -- -- -$0.15 -- --
08/31/2019 Q3 -- -- -$0.13 -- --
07/10/2019 Q2 -- -- -$0.23 -- --
04/10/2019 Q1 -- -- -$0.21 -- --
01/14/2019 Q4 -- -- -$0.25 -- --
08/31/2018 Q3 -- -- -$0.18 -- --
07/12/2018 Q2 -- -- -$0.30 -- --
02/28/2018 Q1 -- -- -$0.20 -- --
11/30/2017 Q4 -- -- -$0.18 -- --
08/31/2017 Q3 -- -- -$0.20 -- --
05/31/2017 Q2 -- -- -$0.15 -- --
04/05/2017 Q1 -- -- -$0.24 -- --
01/11/2017 Q4 -- -- -$0.20 -- --
11/30/2016 Q3 -- -- -$0.37 -- --
07/06/2016 Q2 -- -- -$0.15 -- --
04/08/2016 Q1 -- -- -$0.14 -- --
02/24/2016 Q4 -- -- -$0.21 -- --
12/02/2015 Q3 -- -- -$0.19 -- --
07/02/2015 Q2 -- -- -$0.15 -- --
02/28/2015 Q1 -- -- -$0.15 -- --

Oramed Pharmaceuticals Earnings Questions

  • How Much did Oramed Pharmaceuticals Generate in Revenue Last Quarter?

    Oramed Pharmaceuticals reported -- worth of top line sales in its most recent quarter.

  • Did Oramed Pharmaceuticals Beat Earnings Last Quarter?

    Oramed Pharmaceuticals announced earnings per share of -$0.48 which represents a miss of analyst forecast a -$0.02 per share.

  • Is Oramed Pharmaceuticals Profitable?

    Oramed Pharmaceuticals reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Oramed Pharmaceuticals EPS Next Year?

    Oramed Pharmaceuticals's earnings are forecast to grow from $0.14 per share to -$0.21 per share next year representing an increase of 21.43%.

  • When is Oramed Pharmaceuticals's Earnings Date?

    Oramed Pharmaceuticals's next earnings date is May 9, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock